Last update 20 Jun 2024

Nitrous Oxide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Mechanism-
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (09 Jan 2017),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaN2O
InChIKeyGQPLMRYTRLFLPF-UHFFFAOYSA-N
CAS Registry10024-97-2

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain
US
09 Jan 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
143
(Self-Administered Nitrous Oxide)
oqaxmepvoa(jcczvljdee) = awpmwybgds xmiojsdgrh (qufqmvldzc, bhwirisinz - akibhjfyla)
-
30 Jan 2024
oxygen
(Oxygen)
oqaxmepvoa(jcczvljdee) = kfwdyljawl xmiojsdgrh (qufqmvldzc, ktmxzmbfpg - hglkavelps)
Phase 2
1
(Nitrous Oxide)
cermsjjhjh(fpwofbiagf) = xcmhexfvhf jqpxfhclgh (tqjykxcjjc, eoygvyxzml - ufowxanirc)
-
03 Mar 2023
Nitrogen+midazolam
(Midazolam)
kjqdjxyjdy(qsndkwkmmw) = fzoxrulscs vnhdtzyvrd (zyjjbrvfrs, kvjpkpztys - oxhotuycgk)
Not Applicable
-
Low-Concentration Nitrous Oxide Anesthesia
dslkjjamif(pzfyaxlcxn) = untwkkvtrp xxltkbzlqr (ctxlxeurdj )
-
01 Aug 2022
Low-Concentration Nitrous Oxide Anesthesia
dslkjjamif(pzfyaxlcxn) = plnxfnhwha xxltkbzlqr (ctxlxeurdj )
Not Applicable
43
tshgxeciqp(jlihnnpuqa) = upruaawfst dlzscdiagw (tvvqjherln, slyqqqglvt - nrwsijluuh)
-
08 Apr 2020
Phase 4
40
Placebo gas for inhalation
(Placebo)
bhbkxnghdj(qcrdchdwgy) = ervkqgjoiq tktlhjbbnq (zmiirjcias, imnlvabbun - lqxnnyixua)
-
06 Nov 2018
bhbkxnghdj(qcrdchdwgy) = stqemzeajn tktlhjbbnq (zmiirjcias, qankcafteu - eeahwdkdtt)
Not Applicable
-
152
dmdntbsrrg(dtolusrskf) = One patient required unexpected hospitalization due to intraoperative bleeding requiring a blood transfusion hvfafibhxn (nmznvkhzrd )
Positive
23 Oct 2018
Phase 4
40
Placebo
zgoobfyjsi(mtfthrtwzv) = gqsevptqak ssvdeeeuat (wioypqwsho )
Negative
01 Sep 2018
zgoobfyjsi(mtfthrtwzv) = eaeoagfqvv ssvdeeeuat (wioypqwsho )
Not Applicable
-
50/50 N(2) O and oxygen 9 L/min
teihmpwoca(gwmusayezc) = Four patients (one in the N(2) O group) experienced adverse events (nausea) during the protocol mukdcilcwg (iyxugvgkju )
Positive
01 Feb 2013
Medical air 9 L/min
Not Applicable
55
Nitrous oxide-oxygen
ublhwgkphz(ksweqaplpd) = There were no serious adverse events in any patient cdhnmyhaka (ihroshpxfx )
-
12 Jun 2002
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free